ClinicalTrials.Veeva

Menu

Brief Intervention for Drug Abusing Adolescents

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status and phase

Completed
Phase 2

Conditions

Drug Abuse

Treatments

Behavioral: brief intervention (cognitive-behavioral therapy)

Study type

Interventional

Funder types

Other

Identifiers

NCT00350909
0308S51681

Details and patient eligibility

About

The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the St. Paul Public Schools. This intervention aims to reduce post-treatment drug use behaviors and enhance drug-use resistant cognitions and problem-solving skills.

Full description

The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the St. Paul Public Schools. This intervention aims to reduce post-treatment drug use behaviors and enhance drug-use resistant cognitions and problem-solving skills.

Specifically, we propose a randomized clinical trial to evaluate the efficacy of a cognitive-behavioral therapy on key process and outcome dimensions among school-based youth with mild-to-moderate drug abuse (MMDA). The experimental treatment is designated Brief Cognitive Behavioral Intervention (BCBI) given its theoretical foundation in stage of change theory used to coordinate modules on Rational-Emotive Therapy and Problem Solving Therapy. BCBI will be compared against a second experimental treatment that consists of BCBI and a single parent session (BCBI+P) and an assessment only condition (control). The importance of clarifying mechanisms in drug treatment research will be explored with respect to a limited number of treatment and individual factors that have emerged as promising mediating and moderating factors, such as cognitive and problem solving factors, parenting practices, and peer group influences.

Enrollment

160 patients

Sex

All

Ages

13 to 19 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. student at a local school
  2. meets DSM-IV criteria for a substance abuse disorder for at least one drug
  3. student and parent both agree to participate in the intervention study

Exclusion criteria

  1. meets criteria for at least one DSM-IV substance dependence disorder
  2. meets criteria for a psychotic disorder or a learning disability

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

160 participants in 2 patient groups

1
Experimental group
Description:
One arm was a 2-session brief intervention with both sessions involving only the adolescent. Each session was a 60 minute individual session with the counselor.
Treatment:
Behavioral: brief intervention (cognitive-behavioral therapy)
2
Active Comparator group
Description:
The other arm was a 3-session brief intervention, with 2 sessions involving the adolescent and one session with the parent. Each of these individual sessions were 60 minutes.
Treatment:
Behavioral: brief intervention (cognitive-behavioral therapy)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems